Abstract | BACKGROUND:
Tadenan (a Pygeum africanum extract) is a drug used in the treatment of benign prostatic hyperplasia. Its effects on prostate fibroblast proliferation and bladder function after partial outlet obstruction have been demonstrated in various pharmacological studies. However, its effects at the molecular level are poorly documented. METHODS: RESULTS:
Tadenan treatment of castrated/ testosterone-replaced rats was performed in order to interfere with prostatic cell proliferation. This experimental approach resulted in increases of: 1) VIP effect on adenylyl cyclase stimulation through alpha(s) G-subunit; 2) alpha(i) activation by low Gpp[NH]p doses (in the presence of forskolin); and 3) alpha(s), alpha(i1/2), and alpha(i3/0) levels. However, there were no modifications in membranes from quiescent, nonproliferating prostates (untreated rats). CONCLUSIONS: The observed regulatory role of Tadenan on various prostatic components of the adenylyl cyclase system, together with previous findings on protein kinase C-mediated signal transduction, open a complex array of possibilities of direct actions of this phytotherapeutic agent in the prostate.
|
Authors | R M Solano, M O García-Fernández, C Clemente, M Querol, F Bellamy, M Sanchez-Chapado, J C Prieto, M J Carmena |
Journal | The Prostate
(Prostate)
Vol. 45
Issue 3
Pg. 245-52
(Nov 01 2000)
ISSN: 0270-4137 [Print] United States |
PMID | 11074527
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2000 Wiley-Liss, Inc. |
Chemical References |
- Fatty Alcohols
- Growth Inhibitors
- Plant Extracts
- Receptors, Vasoactive Intestinal Peptide
- Tadenan
- GTP-Binding Proteins
- Adenylyl Cyclases
|
Topics |
- Adenylyl Cyclases
(drug effects, metabolism)
- Administration, Oral
- Animals
- Cell Division
- Fatty Alcohols
(pharmacology)
- GTP-Binding Proteins
(drug effects, physiology)
- Growth Inhibitors
(pharmacology)
- Male
- Plant Extracts
- Prostate
(drug effects, enzymology, pathology)
- Rats
- Rats, Wistar
- Receptors, Vasoactive Intestinal Peptide
(drug effects, physiology)
|